FRI0234 Choice of Biologic Therapy Following Rituximab: Influencing Factors in a French Multicenter Cohort of Rheumatoid Arthritis

doi 10.1136/annrheumdis-2017-eular.5472
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ Publishing Group Ltd and European League Against Rheumatism

Related search

Factors Determining Long-Term Success of Biologic Therapy in Rheumatoid Arthritis

Modern Rheumatology Journal
2015English

Rituximab Therapy in Greek Patients With Rheumatoid Arthritis

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2008English

Selected Problems of Biologic Therapy in Rheumatoid Arthritis Patients – Pregnancy During Therapy.

Reumatologia
RheumatologyAllergyImmunology
2013English

Factors Correlated With Improvement of Endothelial Dysfunction During Rituximab Therapy in Patients With Rheumatoid Arthritis

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2013English

Safety of Rituximab in Rheumatoid Arthritis

Reumatismo
Rheumatology
2011English

Biologic Treatments for Rheumatoid Arthritis

Trends in Urology & Men's Health
2019English

Reasons for Discontinuation of Subcutaneous Biologic Therapy in the Treatment of Rheumatoid Arthritis: A Patient Perspective

Patient Preference and Adherence
PharmacologyHealth PolicyMedicineToxicologySocial SciencesPharmaceutics
2015English

B Cell Therapy for Rheumatoid Arthritis: The Rituximab (Anti-Cd20) Experience

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2003English

Factors Associated With Gastrointestinal Perforation in a Cohort of Patients With Rheumatoid Arthritis

Arthritis Care and Research
Rheumatology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy